Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial

Authors

Institutions

Publication Details

Journal
Journal of Psychopharmacology
Published
2025-08-29
DOI
https://doi.org/10.1177/02698811251362390
Citations
4
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
9.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial

Hollie Simmons, Nadav Liam Modlin, Guy M. Goodwin, James Rucker et al.
4 citations
Journal of Psychopharmacology
Psychedelics and Drug Studies
9.23
article

Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial

Hollie Simmons, Nadav Liam Modlin, Guy M. Goodwin, James Rucker, Niall M. McGowan, Manish Agrawal, Rachel Yehuda, Shriya Das, Agata Tofil-Kaluza
article en
4 citations

Abstract

No abstract available for this paper.
Journal of Psychopharmacology
Pathfinder International (US), King's College London (GB), Pathways Behavioral Services (US), James J. Peters VA Medical Center (US), Vital Therapies (United States) (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 2%
Psychedelics and Drug Studies
9.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.